CVMA | News & Events | Key Updates for Veterinary Drug Stakeholders

News, Events & COVID-19 RESOURCES

Key Updates for Veterinary Drug Stakeholders

July 20, 2021

Reminder: MoRS guidance consultation period extension
As you are already aware, we are seeking your feedback on the proposed updates to the guidance document: Management of regulatory submissions. We have extended the consultation period and will continue to receive feedback until July 27, 2021. Send your ideas or comments to

Update: VDD office relocation
As of the end of July 2021, our current office is moving. As you know, we have transitioned away from receiving physical deliveries of submission-related documents over the past year, and with the upcoming move of our office, it is essential that all sponsors continue to send all regulatory submissions electronically. For more information about how to send submissions electronically, please contact

Updates: Veterinary Adverse Drug Reactions
We have updated the Adverse Event Reporting form to improve its usability. We also took the opportunity to update our adverse veterinary drug reaction webpage to provide additional helpful information about adverse event reporting. 

Final List: Maximum Residue Limits (MRLs) for Veterinary Drugs in Foods
Based on the 2020 consultation and feedback received, the final list of MRLs has been published. The amended list includes new MRLs for 5 veterinary drugs and revisions to existing MRLs for 2 drugs. For more information and the final list, refer here: Final Notices to Amend the List of MRLs for Veterinary Drugs in Foods.

Updated List C: Veterinary Health Products (VHPs)
List C has been updated with 97 new substances as well as 106 modifications to existing substances, providing further access to VHPs. Updates will include substances for use in a number of species including fin fish, dairy cattle, and a number of minor species. The List now has a total of 781 active substances, including almost 300 for food producing animals.